Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
VRCA on Nasdaq
Shares outstanding
8,810,762
Price per share
$8.30
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
5,196,096
Total reported value
$43,155,907
% of total 13F portfolios
0%
Share change
+2,491,386
Value change
+$20,755,741
Number of holders
49
Price from insider filings
$8.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Manning Paul B 50% $28,437,789 8,056,031 Paul B Manning 25 Nov 2025
Caligan Partners LP 10% 0% $43,635,492 6,503,054 0% Caligan Partners LP 26 Dec 2025
Affinity Asset Advisors, LLC 5.5% +0.6% $7,346,762 884,172 0% Affinity Asset Advisors, LLC 22 Jan 2026
ARMISTICE CAPITAL, LLC 5% -25% $3,649,153 -$1,656,149 439,657 -31% Armistice Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 49 institutional investors reported holding 5,196,096 shares of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA). This represents 59% of the company’s total 8,810,762 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 13% 1,118,925 +75% 0.23% $9,298,267
Caligan Partners LP 10% 923,910 0% 0.7% $7,677,692
Affinity Asset Advisors, LLC 8% 707,338 0.42% $5,877,979
Velan Capital Investment Management LP 5.4% 471,559 2.3% $3,918,655
Stonepine Capital Management, LLC 4% 353,669 2.3% $2,938,989
BOOTHBAY FUND MANAGEMENT, LLC 3.2% 280,734 0% 0.06% $2,332,900
Kalehua Capital Management LLC 2.7% 235,779 0% 2% $1,959,323
DAFNA Capital Management LLC 2% 173,451 0.33% $1,441,378
VANGUARD GROUP INC 1.6% 138,194 -39% 0% $1,148,392
TWO SIGMA INVESTMENTS, LP 1.3% 118,218 0% $982,392
JANE STREET GROUP, LLC 1.2% 101,722 0% $845,310
MARSHALL WACE, LLP 0.97% 85,173 0% $707,786
GEODE CAPITAL MANAGEMENT, LLC 0.77% 67,659 0% 0% $562,388
TWO SIGMA ADVISERS, LP 0.5% 44,430 0% $369,213
Squarepoint Ops LLC 0.38% 33,270 0% $276,474
Sovran Advisors, LLC 0.37% 32,658 -56% 0.02% $248,527
RENAISSANCE TECHNOLOGIES LLC 0.3% 26,400 -9.6% 0% $219,384
Mariner, LLC 0.28% 24,544 -0.02% 0% $203,961
STATE STREET CORP 0.27% 23,481 +14% 0% $195,127
MILLENNIUM MANAGEMENT LLC 0.26% 23,123 -68% 0% $192,152
OMERS ADMINISTRATION Corp 0.26% 22,600 0% $187,806
MORGAN STANLEY 0.25% 22,009 +1.5% 0% $182,894
NORTHERN TRUST CORP 0.23% 20,024 -0.03% 0% $166,400
GOLDMAN SACHS GROUP INC 0.21% 18,621 0% $154,741
HRT FINANCIAL LP 0.2% 17,356 0% $144,000

Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,196,096 $43,155,907 +$20,755,741 $8.31 49
2025 Q3 2,468,945 $10,583,119 +$10,479,755 $4.31 31
2025 Q2 194,004 $102,830 +$102,830 $0.53 4